<DOC>
	<DOC>NCT00244608</DOC>
	<brief_summary>The purpose of this study is to determine if a flexible dose of Symbicort has a similar effect on the airways of patients with asthma as a higher fixed-dose of Symbicort with additional glucocorticosteroids added.</brief_summary>
	<brief_title>A Comparison of the Control of Asthma Provided by Symbicort® Turbuhaler® Versus Symbicort® Turbuhaler® Plus Pulmicort® Turbuhaler® Plus Terbutaline Turbuhaler®</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Budesonide</mesh_term>
	<mesh_term>Terbutaline</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
	<criteria>Diagnosis of asthma for at least 6 months Prescribed daily use of glucocorticosteroids for at least 3 months prior to visit one Respiratory infection affecting asthma within 30 days prior to study Intake of oral, rectal, or parenteral glucocorticosteroids within 30 days prior to study Any significant disease or disorder that may jeopardize the safety of the patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
</DOC>